Cargando…

White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments

Multiple sclerosis (MS) is a major demyelinating disease of the central nervous system; however, its exact mechanism is unknown. This study aimed to elucidate the profile of white blood cells (WBCs) in the acute phase of an MS attack. Sixty-four patients with MS at the time of diagnosis and 2492 age...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaishi, Tetsuya, Misu, Tatsuro, Fujihara, Kazuo, Nakaya, Naoki, Nakamura, Tomohiro, Kogure, Mana, Hatanaka, Rieko, Itabashi, Fumi, Kanno, Ikumi, Takahashi, Toshiyuki, Kuroda, Hiroshi, Fujimori, Juichi, Takai, Yoshiki, Nishiyama, Shuhei, Kaneko, Kimihiko, Ishii, Tadashi, Aoki, Masashi, Nakashima, Ichiro, Hozawa, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595427/
https://www.ncbi.nlm.nih.gov/pubmed/34785750
http://dx.doi.org/10.1038/s41598-021-01942-8
_version_ 1784600197961089024
author Akaishi, Tetsuya
Misu, Tatsuro
Fujihara, Kazuo
Nakaya, Naoki
Nakamura, Tomohiro
Kogure, Mana
Hatanaka, Rieko
Itabashi, Fumi
Kanno, Ikumi
Takahashi, Toshiyuki
Kuroda, Hiroshi
Fujimori, Juichi
Takai, Yoshiki
Nishiyama, Shuhei
Kaneko, Kimihiko
Ishii, Tadashi
Aoki, Masashi
Nakashima, Ichiro
Hozawa, Atsushi
author_facet Akaishi, Tetsuya
Misu, Tatsuro
Fujihara, Kazuo
Nakaya, Naoki
Nakamura, Tomohiro
Kogure, Mana
Hatanaka, Rieko
Itabashi, Fumi
Kanno, Ikumi
Takahashi, Toshiyuki
Kuroda, Hiroshi
Fujimori, Juichi
Takai, Yoshiki
Nishiyama, Shuhei
Kaneko, Kimihiko
Ishii, Tadashi
Aoki, Masashi
Nakashima, Ichiro
Hozawa, Atsushi
author_sort Akaishi, Tetsuya
collection PubMed
description Multiple sclerosis (MS) is a major demyelinating disease of the central nervous system; however, its exact mechanism is unknown. This study aimed to elucidate the profile of white blood cells (WBCs) in the acute phase of an MS attack. Sixty-four patients with MS at the time of diagnosis and 2492 age- and sex-adjusted healthy controls (HCs) were enrolled. Data regarding the blood cell counts were compared between the groups. The total WBC (p < 0.0001), monocyte (p < 0.0001), basophil (p = 0.0027), and neutrophil (p < 0.0001) counts were higher in the MS group than in the HC group, whereas the lymphocyte and eosinophil counts did not differ. Adjustments for the smoking status and body mass index yielded the same results. The total and differential WBC counts of the patients with MS did not correlate with the counts of T2 hyperintense brain lesions or the levels of neurological disturbance. In summary, patients with MS showed elevated counts of total WBCs, monocytes, basophils, and neutrophils at the time of diagnosis. However, the clinical relevance of these biomarkers in the context of the development and progression of MS remains unclear.
format Online
Article
Text
id pubmed-8595427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85954272021-11-17 White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments Akaishi, Tetsuya Misu, Tatsuro Fujihara, Kazuo Nakaya, Naoki Nakamura, Tomohiro Kogure, Mana Hatanaka, Rieko Itabashi, Fumi Kanno, Ikumi Takahashi, Toshiyuki Kuroda, Hiroshi Fujimori, Juichi Takai, Yoshiki Nishiyama, Shuhei Kaneko, Kimihiko Ishii, Tadashi Aoki, Masashi Nakashima, Ichiro Hozawa, Atsushi Sci Rep Article Multiple sclerosis (MS) is a major demyelinating disease of the central nervous system; however, its exact mechanism is unknown. This study aimed to elucidate the profile of white blood cells (WBCs) in the acute phase of an MS attack. Sixty-four patients with MS at the time of diagnosis and 2492 age- and sex-adjusted healthy controls (HCs) were enrolled. Data regarding the blood cell counts were compared between the groups. The total WBC (p < 0.0001), monocyte (p < 0.0001), basophil (p = 0.0027), and neutrophil (p < 0.0001) counts were higher in the MS group than in the HC group, whereas the lymphocyte and eosinophil counts did not differ. Adjustments for the smoking status and body mass index yielded the same results. The total and differential WBC counts of the patients with MS did not correlate with the counts of T2 hyperintense brain lesions or the levels of neurological disturbance. In summary, patients with MS showed elevated counts of total WBCs, monocytes, basophils, and neutrophils at the time of diagnosis. However, the clinical relevance of these biomarkers in the context of the development and progression of MS remains unclear. Nature Publishing Group UK 2021-11-16 /pmc/articles/PMC8595427/ /pubmed/34785750 http://dx.doi.org/10.1038/s41598-021-01942-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Akaishi, Tetsuya
Misu, Tatsuro
Fujihara, Kazuo
Nakaya, Naoki
Nakamura, Tomohiro
Kogure, Mana
Hatanaka, Rieko
Itabashi, Fumi
Kanno, Ikumi
Takahashi, Toshiyuki
Kuroda, Hiroshi
Fujimori, Juichi
Takai, Yoshiki
Nishiyama, Shuhei
Kaneko, Kimihiko
Ishii, Tadashi
Aoki, Masashi
Nakashima, Ichiro
Hozawa, Atsushi
White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
title White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
title_full White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
title_fullStr White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
title_full_unstemmed White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
title_short White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
title_sort white blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595427/
https://www.ncbi.nlm.nih.gov/pubmed/34785750
http://dx.doi.org/10.1038/s41598-021-01942-8
work_keys_str_mv AT akaishitetsuya whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT misutatsuro whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT fujiharakazuo whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT nakayanaoki whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT nakamuratomohiro whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT koguremana whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT hatanakarieko whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT itabashifumi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT kannoikumi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT takahashitoshiyuki whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT kurodahiroshi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT fujimorijuichi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT takaiyoshiki whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT nishiyamashuhei whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT kanekokimihiko whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT ishiitadashi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT aokimasashi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT nakashimaichiro whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments
AT hozawaatsushi whitebloodcellcountprofilesinmultiplesclerosisduringattacksbeforetheinitiationofacuteandchronictreatments